Davis et al. JCEM Supplementary Materials
Supplementary materials for "Efficacy and Safety of Lonapegsomatropin in Children With Turner Syndrome: 52-Week Results From the Randomized Phase 2 New InsiGHTS Trial" (Davis et al. J Clin Endocrinol Metab, 2026; dgag436, https://doi.org/10.1210/clinem/dgag436)
Authors
- Diane E. J. Stafford (ORCID: https://orcid.org/0000-0002-1911-0360)
- Doris Fadoju (ORCID: https://orcid.org/0000-0002-8117-8438)
- Sohair Abdelrahman
- Katie Woods
- Mary Jennifer Abuzzahab
- Shanlee Davis (ORCID: https://orcid.org/0000-0002-0304-9550)
- Allison Komirenko (ORCID: https://orcid.org/0000-0001-8844-2804)
- Aimee D Shu (ORCID: https://orcid.org/0000-0003-1801-5289)
- Jennifer M. Iklé (ORCID: https://orcid.org/0000-0002-0382-9864)
- Benjamin Udoka Nwosu (ORCID: https://orcid.org/0000-0003-2212-0276)
- Jeanie B. Tryggestad (ORCID: https://orcid.org/0000-0002-5050-0850)
- Iris Gutmark‐Little (ORCID: https://orcid.org/0000-0003-0135-4516)
- Meng Mao (ORCID: https://orcid.org/0000-0002-7745-5359)
- Xiaoa Zhen
- Karen Klein (ORCID: https://orcid.org/0000-0003-4619-5432)
- on behalf of the New InsiGHTS Investigator Group
- Jeanie B. Tryggestad
Publication Details
- Journal
- Figshare
- Published
- 2026-10-26
- DOI
- https://doi.org/10.6084/m9.figshare.32771658
- Primary Topic
- Growth Hormone and Insulin-like Growth Factors
- Type
- article
- Field-Weighted Citation Impact
- 0.00